Frequent Detection of Familial Hypercholesterolemia Mutations in Familial Combined Hyperlipidemia

Journal of the American College of Cardiology

Volumn 52, Issue 19, 2008, Pages 1554-1556

  Jarvik, Gail P ^a   Brunzell, John D ^a   Motulsky, Arno G ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

hypercholesterolemia; hyperlipidemia; LDL receptor; mutations

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; APOLIPOPROTEIN C3; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; TRIACYLGLYCEROL; UPSTREAM STIMULATORY FACTOR 1;

CHOLESTEROL BLOOD LEVEL; EDITORIAL; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; GENE CLUSTER; GENE LOCUS; GENE MUTATION; HUMAN; HYPERTRIGLYCERIDEMIA; LINKAGE ANALYSIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

AGE DISTRIBUTION; CHOLESTEROL, LDL; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; HYPERLIPIDEMIA, FAMILIAL COMBINED; MALE; MIDDLE AGED; MUTATION; PREVALENCE; RECEPTORS, LDL; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 54349129519     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.08.012     Document Type: Editorial

References (22)

1. Goldstein J., Schrott H.G., Hazzard W.R., Bierman E.L., and Motulsky A.G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Invest 52 (1973) 1544-1568
2. Babirak S., Brown B.G., and Brunzell J.D. Familial combined hyperlipidemia and abnormal lipoprotein lipase. Arterioscler Thromb 12 (1992) 1176-1183
3. Zambon A., Brown B.G., Hokanson J.E., Motulsky A.G., and Brunzell J.D. Genetically determined apo B levels and peak LDL density predict angiographic response to intensive lipid-lowering therapy. J Intern Med 259 (2006) 401-409
4. Brunzell J., Albers J.J., Chait A., Grundy S.M., Groszek E., and McDonald G.B. Plasma lipoproteins in familial combined hyperlipidemia and monogenic familial hypertriglyceridemia. J Lipid Res 24 (1983) 147-155
5. Sniderman A., Shapiro S., Marpole D., Skinner B., Teng B., and Kwiterovich Jr. P.O. Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A 77 (1980) 604-608
6. Ayyobi A.F., McGladdery S.H., McNeely M.J., Austin M.A., Motulsky A.G., and Brunzell J.D. Small, dense LDL and elevated apolipoprotein B are the common characteristics for the three major lipid phenotypes of familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 23 (2003) 1289-1294
7. Pajukanta P., Lilja H.E., Sinsheimer J.S., et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36 (2004) 371-376
8. Lee J.C., Weissglas-Volkov D., Kyttala M., et al. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease. Arterioscler Thromb Vasc Biol 27 (2007) 2222-2227
9. Huertas-Vazquez A., Aguilar-Salinas C., Lusis A.J., et al. Familial combined hyperlipidemia in Mexicans: association with upstream transcription factor 1 and linkage on chromosome 16q24.1. Arterioscler Thromb Vasc Biol 25 (2005) 1985-1991
10. Komulainen K., Alanne M., Auro K., et al. Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2 (2006) e69
11. Reiner A.P., Carlson C.S., Jenny N.S., et al. USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arterioscler Thromb Vasc Biol 27 (2007) 2736-2742
12. Babirak S., Iverius P.H., Fujimoto W.Y., and Brunzell J.D. Detection and characterization of the heterozygote state for lipoprotein lipase deficiency. Arteriosclerosis 9 (1989) 326-334
13. Coon H., Myers R.H., Borecki I.B., et al. Replication of linkage of familial combined hyperlipidemia to chromosome 1q with additional heterogeneous effect of apolipoprotein A-I/C-III/A-IV locus. The NHLBI Family Heart Study. Arterioscler Thromb Vasc Biol 20 (2000) 2275-2280
14. Eichenbaum-Voline S., Olivier M., Jones E.L., et al. Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia. Arterioscler Thromb Vasc Biol 24 (2004) 167-174
15. Varret M., Abifadel M., Rabes J.P., and Boileau C. Genetic heterogeneity of autosomal dominant hypercholesterolemia. Clin Genet 73 (2008) 1-13
16. Civeira F., Jarauta E., Cenarro A., et al. Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. J Am Coll Cardiol 52 (2008) 1546-1553
17. Tejedor D., Castillo S., Mozas P., et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 51 (2005) 1137-1144
18. Heath K.E., Day I.N., and Humphries S.E. Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene. J Med Genet 37 (2000) 272-280
19. Blesa S., Garcia-Garcia A.B., Martinez-Hervas S., et al. Analysis of sequence variations in the LDL receptor gene in Spain: general gene screening or search for specific alterations?. Clin Chem 52 (2006) 1021-1025
20. Sing C.F., and Orr J.D. Analysis of genetic and environmental sources of variation in serum cholesterol in Tecumseh, Michigan. III. Identification of genetic effects using 12 polymorphic genetic blood marker systems. Am J Hum Genet 28 (1976) 453-464
21. Mahley R., and Rall S. Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver C., Beaudet A.L., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease. 8th edition (2001), McGraw-Hill, New York, NY 2835-2862
22. Breitner J.C., Jarvik G.P., Plassman B.L., Saunders A.M., and Welsh K.A. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years. Alzheimer Dis Assoc Disord 12 (1998) 40-44